tiprankstipranks
Restart Life Sciences (NMLSF)
OTHER OTC:NMLSF
US Market
NMLSF
Restart Life Sciences
RESEARCH TOOLSreports

Restart Life Sciences (NMLSF) Financial Statements

31 Followers

Restart Life Sciences Financial Overview

Restart Life Sciences's market cap is currently $3.32M. The company's EPS TTM is $-0.0271; its P/E ratio is -1.83; Restart Life Sciences is scheduled to report earnings on August 27, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Mar 25Mar 24Mar 23Mar 22
Income Statement
Total RevenueC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross ProfitC$ 0.00C$ 0.00C$ 25.41KC$ -3.79KC$ -5.00K
Operating IncomeC$ -1.35MC$ -658.51KC$ -1.23MC$ -1.94MC$ -2.93M
EBITDAC$ -1.34MC$ -656.20KC$ -1.20MC$ -1.84MC$ -2.68M
Net IncomeC$ -1.39MC$ 224.75KC$ -1.22MC$ -3.76MC$ -2.68M
Balance Sheet
Cash & Short-Term InvestmentsC$ 1.65MC$ 169.95KC$ 8.09KC$ 266.52KC$ 218.73K
Total AssetsC$ 1.77MC$ 190.40KC$ 31.06KC$ 296.79KC$ 881.16K
Total DebtC$ 245.36KC$ 79.88KC$ 0.00C$ 0.00C$ 0.00
Net DebtC$ -1.35MC$ 68.56KC$ -8.09KC$ -266.52KC$ -218.73K
Total LiabilitiesC$ 480.21KC$ 489.47KC$ 841.66KC$ 255.44KC$ 422.06K
Stockholders' EquityC$ 1.29MC$ -299.07KC$ -810.60KC$ 41.34KC$ 459.10K
Cash Flow
Free Cash FlowC$ -717.22KC$ -71.77KC$ -277.53KC$ -1.44MC$ -1.95M
Operating Cash FlowC$ -717.22KC$ -71.77KC$ -277.53KC$ -1.44MC$ -1.95M
Investing Cash FlowC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 29.64K
Financing Cash FlowC$ 2.30MC$ 75.00KC$ 19.10KC$ 1.49MC$ 0.00
Currency in CAD

Restart Life Sciences Earnings and Revenue History

Income Statement >

Restart Life Sciences Debt to Assets

Balance Sheet >

Restart Life Sciences Cash Flow

Cash Flow >

Restart Life Sciences Forecast EPS vs Actual EPS

Earnings >